Comparative Pharmacology
Head-to-head clinical analysis: FLUCONAZOLE versus MYCELEX 7.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLUCONAZOLE versus MYCELEX 7.
Fluconazole vs MYCELEX-7
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluconazole is a triazole antifungal agent that inhibits fungal cytochrome P450 14α-demethylase, thereby blocking the conversion of lanosterol to ergosterol, an essential component of the fungal cell membrane.
Clotrimazole, an azole antifungal, inhibits fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and increasing membrane permeability.
200-400 mg orally or intravenously once daily. For candidemia and other invasive Candida infections, loading dose of 800 mg (12 mg/kg) on day 1, then 400 mg (6 mg/kg) daily.
Clotrimazole 100 mg vaginal tablet inserted intravaginally once daily at bedtime for 7 days.
None Documented
None Documented
Clinical Note
moderateMethoxsalen + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Methoxsalen."
Clinical Note
moderateCyclophosphamide + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Cyclophosphamide."
Clinical Note
moderatePaclitaxel + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Paclitaxel."
Clinical Note
moderateDocetaxel + Fluconazole
Terminal elimination half-life ~30 hours (range 20-50 h) in patients with normal renal function; prolonged in renal impairment (up to 98 h in CrCl <20 mL/min). This long half-life supports once-daily dosing and allows loading dose administration.
The systemic half-life of clotrimazole following vaginal administration is approximately 0.5–1 hour due to rapid metabolism and elimination. This short half-life reflects minimal systemic absorption (3–10%).
Renal: approximately 80% as unchanged drug; biliary/fecal: ~11% as metabolites and unchanged drug.
Primarily via feces as unchanged drug (approx. 50%) and metabolites. Renal excretion of unchanged drug is minimal (<1%) as the drug is poorly absorbed from the vagina. Biliary excretion contributes to fecal elimination.
Category C
Category C
Azole Antifungal
Azole Antifungal
"The metabolism of Fluconazole can be decreased when combined with Docetaxel."